|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/06 | (2013.01) |
| A61K 31/395 | (2006.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61K 31/502 | (2006.01) | ||
| A61K 31/55 | (2013.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61K 38/05 | (2013.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61K 31/407 | (2013.01) | ||
| A61K 31/58 | (2013.01) | ||
| A61K 31/573 | (2013.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61K 31/69 | (2013.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 31/427 | (2013.01) | ||
| A61K 31/502 | (2013.01) |
| (11) | Number of the document | 3148529 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15715192.9 |
| Date of filing the European patent application | 2015-03-26 | |
| (97) | Date of publication of the European application | 2017-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/056667 |
| Date | 2015-03-26 |
| (87) | Number | WO 2015/180865 |
| Date | 2015-12-03 |
| (30) | Number | Date | Country code |
| 201409471 | 2014-05-28 | GB |
| (72) |
MEHRLING, Thomas , CH
FESTUCCIA, Claudio , IT
|
| (73) |
Euro-Celtique S.A. ,
1, rue Jean Piret, 2350 Luxembourg,
LU
|
| (54) | COMPOUNDS FOR TREATING BRAIN CANCER |
| COMPOUNDS FOR TREATING BRAIN CANCER |